Enlitic (ASX:ENL) signed a three-year deal with Bayer Healthcare to integrate its Endex medical imaging management software into the pharmaceutical firm's proprietary radiation dose management system, according to a Wednesday filing with the Australian bourse.
The software will be first rolled out to 50 radiation sites with an option to expand to 200 sites, the filing said.
The deal is expected to generate $50,000 per year during the contract term, which may be extended depending on site expansion.
Enlitic's shares surged almost 13% in recent Wednesday trade.
Price (AUD): $0.07, Change: $+0.01, Percent Change: +12.50%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.